Serum Circulating Fatty Acid Synthase As A Diagnostic Biomarker For Chronic Limb-Threatening Ischemia
This activity was presented at 2020 VRIC as part of Abstract Session 2: Atherosclerotic Disease and Role of the Immune System.
This study showed that circulating fatty acid synthase (cFAS) is independently associated with CLTI but not DM. Future studies may explore using cFAS as biomarker for severity of PAD to guide clinical management, or as a target for development of medical therapeutics.
Professional Practice Gap
This study evaluates the potential association between serum biomarkers and clinical severity in patients with diabetes and peripheral artery disease.
To create a virtual environment for the exchange of basic and translational vascular science that stimulates thoughtful discussion and motivates participants to discover solutions to important problems affecting vascular patients.
The opinions or views expressed on the SVS OnDemand platform and the SVS Video Library are those of the faculty and do not necessarily reflect the opinions, recommendations, or endorsement of SVS. Participants should critically appraise the information presented and are encouraged to consult appropriate resources for information surrounding any product or device mentioned. Information presented, as well as publications, technologies, products and/or services discussed, are intended to inform the learner about the knowledge, techniques, and experiences of SVS faculty who are willing to share such information with colleagues. The SVS disclaims any and all liability for damages to any individual user for all claims which may result from the use of said information, publications, technologies, products and/or services and events.